Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells

American Journal of Pathology

Volumn 148, Issue 1, 1996, Pages 105-119

  Waldman, W James ^a,b   Knight, Deborah A ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN;

ARTERIOSCLEROSIS; ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GRAFT REJECTION; HISTOCOMPATIBILITY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; INFECTION RISK; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIUM; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-DR ANTIGENS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 0030049976     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Beschorner WE, Hutchins GM, Burns WH, Saral R, Tutschka PJ, Santos GW: Cytomegalovirus pneumonia in bone marrow transplant recipients, miliary and diffuse patterns Am Rev Respir Dis 1980, 122 107-114
2. Ramsey PG, Rubin RH, Tolkoff-Rubin NE, Cosimi AB, Russell PS, Greene R: The renal transplant patient with fever and pulmonary infiltrates etiology, clinical manifestations, and management Medicine 1980, 59:206-222
3. Foucar E, Mukai K, Foucar K, Sutherland DER, Van Buren CT: Colon ulceration in lethal cytomegalovirus infection. Am J Clin Pathol 1981, 76 788-801
4. Spencer GD, Shulman HM, Myerson D, Thomas ED, McDonald GB: Diffuse intestinal ulceration after marrow transplantation: a clinicopathologic study of 13 patients Hum Pathol 1986, 17.621-633
5. Paya CV, Hermans PE, Wiesner RH, Ludwig J, Smith TF, Rakela J, Krom RAF. Cytomegalovirus hepatitis in liver transplantation, prospective analysis of 93 consecutive orthotopic liver transplantations J Infect Dis 1989, 160.752-758
6. Augsburger JJ, Henry RY. Retinal aneurysms in adult cytomegalovirus retinitis. Am J Ophthalmol 1978, 86. 794-797
7. Peterson PK, Balfour HH Jr, Marker SC, Fryd DS, Howard RJ, Simmons RL. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation Medicine 1980, 59 283-300
8. Lopez C, Simmons RL, Mauer SM, Najarian JS, Good RA: Association of renal allograft rejection with virus infections Am J Med 1974, 56:280-289
9. von Willebrand E, Pettersson E, Ahonen J, Hayry P CMV infection, class II antigen expression, and human kidney allograft rejection Transplantation 1986, 42: 364-367
10. Bruning JH, Bruggeman CA, Vriesman PJVB. The effect of cytomegalovirus infection on renal allograft function and rejection in a rat model Transplantation 1989, 47:742-744
11. Weimar W, Balk AHMM, Metselaar HJ, Mochtar B, Rothbarth PH: On the relation between cytomegalovirus infection and rejection after heart transplantation Transplantation 1991, 52.162-164
12. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE: Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis JAMA 1989, 261.3561-3566
13. Normann SJ, Salomon DR, Leelachaikul P, Khan SR, Staples ED, Alexander J, Mayfield WR, Knauf DG, Sadler LA, Selman S: Acute vascular rejection of the coronary arteries in human heart transplantation, pathology and correlations with immunosuppression and cytomegalovirus infection. J Heart Lung Transplant 1991, 10:674-687
14. Everett JP, Hershberger RE, Norman DJ, Chou S, Ratkovec RM, Cobanoglu A, Ott GY, Hosenpud JD: Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J Heart Lung Transplant 1992, 11:S133-S137
15. Hruban RH, Beschorner WE, Baumgartner WA, Augustine SM, Ren H, Reitz BA, Hutchins GM: Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis. Am J Pathol 1990, 137 871-882
16. Salomon RN, Hughes CCW, Schoen FJ, Payne DD, Pober JS, Libby P: Human coronary transplantation-associated arteriosclerosis evidence for a chronic immune reaction to activated graft endothelial cells Am J Pathol 1991, 138:791-798
17. Johnson DE, Gao SZ, Schroeder JS, DeCampli WM, Billingham ME. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant 1989, 8:349-359
18. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990, 70 427-451
19. Craighead JE. Pulmonary cytomegalovirus infection in the adult. Am J Pathol 1971, 63:487-504
20. Lin CS, Penha PD, Krishnan MN, Zak FG Cytomegalic inclusion disease of the skin. Arch Dermatol 1981, 117: 282-284
21. Toorkey CB, Carrigan DR: Immunohistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues. J Infect Dis 1989, 160: 741-751
22. Roberts WH, Sneddon JM, Waldman WJ, Stephens RE Cytomegalovirus infection of gastrointestinal endothelium demonstrated by simultaneous nucleic acid hybridization and immunohistochemistry. Arch Pathol Lab Med 1989, 113.461-464
23. Myerson D, Hackman RC, Nelson JA, Ward DC, McDougall JC. Widespread presence of histologically occult cytomegalovirus Hum Pathol 1984, 15:430-439
24. Ho DD, Rota TR, Andrews CA, Hirsch MS: Replication of human cytomegalovirus in endothelial cells J Infect Dis 1984, 150:956-957
25. Smiley ML, Mar EC, Huang ES. Cytomegalovirus infection and viral-induced transformation of human endothelial cells. J Med Virol 1988, 25:213-226
26. Bruggeman CA, Debie WHM, Muller AD, Schutte B, van Dam-Mieras MCE: Cytomegalovirus alters the von Willebrand factor content in human endothelial cells. Thromb Haemost 1988, 59:264-268
27. Waldman WJ, Sneddon JM, Stephens RE, Roberts WH. Enhanced endothelial cytopathogenicity induced by a cytomegalovirus strain propagated in endothelial cells. J Med Virol 1989, 28:223-230
28. Sedmak DD, Orosz CG: The role of vascular endothelial cells in transplantation. Arch Pathol Lab Med 1991, 115.260-265
29. Fuggle SV, Sanderson JB, Gray DWR, Richardson A, Morris PJ: Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys: correlation with intragraft events Transplantation 1993, 55 117-123
30. van Dorp WT, Jonges E, Bruggeman CA, Daha MR, van Es LA, van der Woude FJ Direct induction of MHC class I, but not class II, expression on endothelial cells by cytomegalovirus infection. Transplantation 1989, 48.469-472
31. Sedmak DD, Roberts WH, Stephens RE, Buesching WJ, Morgan LA, Davis DH, Waldman WJ Inability of cytomegalovirus infection of cultured endothelial cells to induce HLA class II antigen expression. Transplantation 1990, 49.458-462
32. Hosenpud JD, Chou S, Wagner CR. Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells. Transplantation 1991, 52:896-903
33. Scholz M, Hamann A, Blaheta RA, Auth MKH, Encke A, Markus BH: Cytomegalovirus- and interferon-related effects on human endothelial cells: cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-γ. Hum Immunol 1992, 35 230-238
34. + T cells Transplantation 1993, 56 1504-1512
35. Sedmak DD, Guglielmo AM, Knight DA, Birmingham DJ, Huang EH, Waldman WJ: Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells Am J Pathol 1994, 144.683-692
36. Sedmak DD, Knight DA, Vook NA, Waldman WJ: Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells Transplantation 1994, 58:1379-1385
37. Waldman WJ, Adams PW, Orosz CG, Sedmak DD T lymphocyte activation by cytomegalovirus-infected, allogeneic cultured human endothelial cells Transplantation 1992, 54:887-896
38. + T cell activation by autologous, HLA class II-negative, cytomegalovirus-infected human endothelial cells. J Cell Biochem 1993, 17D:71
39. Vaccaro PS, Joseph LB, Titterington L, Stephens RE Methods for the initiation and maintenance of human endothelial cell culture. Vasc Surg 1987, 21:391-400
40. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins identification by morphologic and immunologic criteria. J Clin Invest 1973, 52 2745-2756
41. Gimbrone MA Jr, Cotran RS, Folkman J. Human vascular endothelial cells in culture growth and DNA synthesis. J Cell Biol 1974, 60.673-684
42. Huang EH, Morgan CJ, Sedmak DD, Ferguson RM, Orosz CG: Alloantigenicity of human endothelial cells IV. Derivation, characterization and utilization of gonadal vein endothelia to control endothelial alloantigenicity during lymphocyte-endothelial interactions Transplantation 1994, 57.703-711
43. Maciag T, Cerundolo J, Ilsley S, Kelley PR, Forand R: An endothelial cell growth factor from bovine hypothalamus, identification and partial characterization Proc Natl Acad Sci USA 1979, 76.5674-5678
44. Sharma HM, Kauffman EM, Conrad CM. An improved immunoperoxidase technique using horseradish peroxidase avidin D Lab Med 1989, 20.109-112
45. Waldman WJ, Roberts WH, Davis DH, Williams MV, Sedmak DD, Stephens RE. Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells. Arch Virol 1991, 117: 143-164
46. Adams PW, Lee HS, Waldman WJ, Sedmak DD, Morgan CJ, Ward JS, Orosz CG: Alloantigenicity of human endothelial cells. I. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cells J Immunol 1992, 148.3753-3760
47. Boyum A Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 1968, 21:77-89
48. Clouse K, Adams P, Sheridan J, Orosz C: Rapid method for purification of human T lymphocytes for further functional studies J Immunol Methods 1987, 105 253-262
49. Eriksson B, Oberg B, Wahren B. Pyrophosphate analogues as inhibitors of DNA polymerases of cytomegalovirus, herpes simplex virus and cellular origin Biochim Biophys Acta 1982, 696.115-123
50. Herlyn M, Steplewski Z, Herlyn D, Koprowski H: Colorectal carcinoma-specific antigen, detection by means of monoclonal antibodies. Proc Natl Acad Sci USA 1979, 76 1438-1442
51. Herlyn M, Steplewski Z, Herlyn D, Koprowski H CO 17-1A and related monoclonal antibodies: their production and characterization. Hybridoma 1986, 5:S3-S10
52. Tullius SG, Tilney NL: Both alloantigen-dependent and -independent factors influence chronic allograft rejection Transplantation 1995, 59:313-318
53. Billingham ME. Cardiac transplant atherosclerosis. Transplant Proc 1987, 19(No 4, Suppl 5).19-25
54. Yilmaz A, Yilmaz S, Paavonen T, Rappola J, Häyry P: Chronic rejection of rat renal allograft III. Ultrastructure of vascular and glomerular changes. J Exp Pathol 1992, 73:371-385
55. Griffith BP, Paredis IL, Zeevi A, Rabinowich H, Yousem SA, Duquesnoy RJ, Dauber JH, Hardesty RL. Immunologically mediated disease of the airways after pulmonary transplantation. Ann Surg 1988, 208:371-378
56. Ludwig J, Wiesner RH, Batts KP, Perkins JD, Krom RAF The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology 1987, 7.476-483
57. Bacchi CE, Marsh CL, Perkins JD, Carithers RL Jr, McVicar JP, Hudkins KL, Benjamin CD, Harlan JM, Lobb R, Alpers CE: Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection Am J Pathol 1993, 142:579-591
58. Tanaka H, Sukhova GK, Swanson SJ, Cybulsky MI, Schoen FJ, Libby P. Endothelial and smooth muscle cells express leukocyte adhesion molecules heterogeneously during acute rejection of rabbit cardiac allografts Am J Pathol 1994, 144:938-951
59. Ustinov JA, Loginov RJ, Bruggeman CA, van der Meide PH, Hayry P, Lautenschlager I. Cytomegalovirus induces class II expression in rat heart endothelial cells. J Heart Lung Transplant 1993, 12:644-651
60. Schwartz RH: T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex Annu Rev Immunol 1985, 3:237-261